[Current questions in the treatment of patients with chronic destructive pulmonary tuberculosis].
D000995:Antitubercular Agents / Q000627:therapeutic use*; D003523:Cycloserine / Q000627:therapeutic use; D005000:Ethionamide / Q000627:therapeutic use; D006801:Humans; D007612:Kanamycin / Q000627:therapeutic use; D011515:Prothionamide / Q000627:therapeutic use; D011718:Pyrazinamide / Q000627:therapeutic use; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*; D014756:Viomycin / Q000627:therapeutic use
D000995:Antitubercular Agents; D011718:Pyrazinamide; D007612:Kanamycin; D011515:Prothionamide; D003523:Cycloserine; D005000:Ethionamide; D014756:Viomycin
Aktual'nye voprosy lecheniia bol'nykh khronicheskim destruktivnym tuberkulezom legkikh